Modern views on an ancient chemical: serotonin effects on cell proliferation, maturation, and apoptosis

Evolutionarily, serotonin existed in plants even before the appearance of animals. Indeed, serotonin may be tied to the evolution of life itself, particularly through the role of tryptophan, its precursor molecule. Tryptophan is an indole-based, essential amino acid which is unique in its light-absorbing properties. In plants, tryptophan-based compounds capture light energy for use in metabolism of glucose and the generation of oxygen and reduced cofactors. Tryptophan, oxygen, and reduced cofactors combine to form serotonin. Serotonin-like molecules direct the growth of light-capturing structures towards the source of light. This morphogenic property also occurs in animal cells, in which serotonin alters the cytoskeleton of cells and thus influences the formation of contacts. In addition, serotonin regulates cell proliferation, migration and maturation in a variety of cell types, including lung, kidney, endothelial cells, mast cells, neurons and astrocytes). In brain, serotonin has interactions with seven families of receptors, numbering at least 14 distinct proteins. Of these, two receptors are important for the purposes of this review. These are the 5-HT1A and 5-HT2A receptors, which in fact have opposing functions in a variety of cellular and behavioral processes. The 5-HT1A receptor develops early in the CNS and is associated with secretion of S-100beta from astrocytes and reduction of c-AMP levels in neurons. These actions provide intracellular stability for the cytoskeleton and result in cell differentiation and cessation of proliferation. Clinically, 5-HT1A receptor drugs decrease brain activity and act as anxiolytics. The 5-HT2A receptor develops more slowly and is associated with glycogenolysis in astrocytes and increased Ca(++) availability in neurons. These actions destabilize the internal cytoskeleton and result in cell proliferation, synaptogenesis, and apoptosis. In humans, 5-HT2A receptor drugs produce hallucinations. The dynamic interactions between the 5-HT1A and 5-HT2A receptors and the cytoskeleton may provide important insights into the etiology of brain disorders and provide novel strategies for their treatment.

[1]  E. Azmitia,et al.  MDMA (ecstasy) effects on cultured serotonergic neurons: evidence for Ca2+-dependent toxicity linked to release , 1990, Brain Research.

[2]  Anat Biegon,et al.  Fetal human brain exhibits a prenatal peak in the density of serotonin 5-HT1A receptors , 1991, Neuroscience Letters.

[3]  Y. Itoyama,et al.  Role of hippocampal serotonergic neurons in ischemic neuronal death , 1997, Behavioural Brain Research.

[4]  K. Bode-Greuel,et al.  Effects of 5‐Hydroxytryptamine1A‐Receptor Agonists on Hippocampal Damage After Transient Forebrain Ischemia in the Mongolian Gerbil , 1990, Stroke.

[5]  H. Hechtman,et al.  Endothelial serotonin uptake and mediation of prostanoid secretion and stress fiber formation. , 1985, Federation proceedings.

[6]  A. Daszuta,et al.  Serotonergic reinnervation reverses lesion‐induced decreases in PSA‐nCAM labeling and proliferation of hippocampal cells in adult rats , 2000, Hippocampus.

[7]  M. Burkhardt,et al.  5‐HydroxytryptamineiA Agonists A New Therapeutic Principle for Stroke Treatment , 1990, Stroke.

[8]  J. Haring,et al.  Serotonin regulates synaptic connections in the dentate molecular layer of adult rats via 5-HT1a receptors: evidence for a glial mechanism , 1998, Brain Research.

[9]  E. Azmitia,et al.  Glial-derived S100b protein selectively inhibits recombinant beta protein kinase C (PKC) phosphorylation of neuron-specific protein F1/GAP43. , 1994, Brain research. Molecular brain research.

[10]  J. Lauder,et al.  S‐100β and insulin‐like growth factor‐II differentially regulate growth of developing serotonin and dopamine neurons in vitro , 1992, Journal of neuroscience research.

[11]  U. Spampinato,et al.  Transient expression of 5-HT1A receptor binding sites in some areas of the rat CNS during postnatal development , 1987, International Journal of Developmental Neuroscience.

[12]  M. Welsh,et al.  Antisense inhibition of glial S100 beta production results in alterations in cell morphology, cytoskeletal organization, and cell proliferation , 1990, The Journal of cell biology.

[13]  H. Hechtman,et al.  Vasoactive amines modulate actin cables (stress fibers) and surface area in cultured bovine endothelium , 1985, Journal of cellular physiology.

[14]  H. Khorana,et al.  Structure-function studies on bacteriorhodopsin. IX. Substitutions of tryptophan residues affect protein-retinal interactions in bacteriorhodopsin. , 1989, The Journal of biological chemistry.

[15]  O. Kellermann,et al.  The mouse 5-HT2B receptor: possible involvement in trophic functions of serotonin. , 1994, Cellular and molecular biology.

[16]  R. Pakala,et al.  Effect of serotonin and thromboxane A2 on endothelial cell proliferation: effect of specific receptor antagonists. , 1998, The Journal of laboratory and clinical medicine.

[17]  G. Borisy,et al.  Microtubule dynamics at the G2/M transition: abrupt breakdown of cytoplasmic microtubules at nuclear envelope breakdown and implications for spindle morphogenesis , 1996, The Journal of cell biology.

[18]  Patricia M. Whitaker-Azmitia,et al.  Serotonin and brain development: role in human developmental diseases , 2001, Brain Research Bulletin.

[19]  E. sanders-Bush,et al.  Developmental switch in the hippocampal serotonin receptor linked to phosphoinositide hydrolysis , 1995, Brain Research.

[20]  J. Prehn,et al.  Protective effects of 5-HT1A receptor agonists against neuronal damage demonstrated in vivo and in vitro , 1994, Journal of neural transmission. Parkinson's disease and dementia section.

[21]  E. Azmitia,et al.  S100 beta and serotonin: a possible astrocytic-neuronal link to neuropathology of Alzheimer's disease. , 1992 .

[22]  E. Azmitia,et al.  Prenatal cocaine exposure disrupts the development of the serotonergic system , 1992, Brain Research.

[23]  J. Raymond,et al.  Serotonin 5-HT2A receptor induces TGF-β1 expression in mesangial cells via ERK: proliferative and fibrotic signals. , 1999, American journal of physiology. Renal physiology.

[24]  G. Aghajanian,et al.  Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release , 1999, Brain Research.

[25]  E. Azmitia,et al.  Postnatal changes in serotonin1 receptors following prenatal alterations in serotonin levels: further evidence for functional fetal serotonin1 receptors , 1987 .

[26]  D. Cox,et al.  Contractile serotonin-2A receptor signal transduction in guinea pig trachea: importance of protein kinase C and extracellular and intracellular calcium but not phosphoinositide hydrolysis. , 1994, The Journal of pharmacology and experimental therapeutics.

[27]  B. Zhivotovsky,et al.  Apoptosis in rat hippocampal dentate gyrus after intraventricular colchicine , 1997, Neuroreport.

[28]  J. Girard,et al.  Identification and Localization of a Skeletal Muscle Secrotonin 5-HT2A Receptor Coupled to the Jak/STAT Pathway* , 1997, The Journal of Biological Chemistry.

[29]  R. Oppenheim,et al.  S100 is present in developing chicken neurons and Schwann cells and promotes motor neuron survival in vivo. , 1992, Journal of neurobiology.

[30]  L. Josefsson,et al.  Cloning of a putative G-protein-coupled receptor from Arabidopsis thaliana. , 1997, European journal of biochemistry.

[31]  E. Azmitia,et al.  Neuro-glial neurotrophic interaction in the S-100β retarded mutant mouse (Polydactyly Nagoya). II. Co-cultures study , 1994, Brain Research.

[32]  T. Zetterström,et al.  Serotonergic regulation of mRNA expression of Arc, an immediate early gene selectively localized at neuronal dendrites , 2000, Neuropharmacology.

[33]  M. Madesh,et al.  Control of apoptosis by IP(3) and ryanodine receptor driven calcium signals. , 2000, Cell calcium.

[34]  B. Zhivotovsky,et al.  Cytochrome c release and caspase‐3 activation during colchicine‐induced apoptosis of cerebellar granule cells , 1999, The European journal of neuroscience.

[35]  L. Goya,et al.  Effects of serotonin on tyrosine hydroxylase and tau protein in a human neuroblastoma cell line. , 1991, Advances in experimental medicine and biology.

[36]  R. Yu,et al.  Differential regulation of mitogen-activated protein kinases by microtubule-binding agents in human breast cancer cells , 1999, Oncogene.

[37]  E. Azmitia,et al.  S-100B but not NGF, EGF, insulin or calmodulin is a CNS serotonergic growth factor , 1990, Brain Research.

[38]  Probal Banerjee,et al.  Agonist Stimulation of the Serotonin1A Receptor Causes Suppression of Anoxia‐Induced Apoptosis via Mitogen‐Activated Protein Kinase in Neuronal HN2‐5 Cells , 1999, Journal of neurochemistry.

[39]  E. Hansson,et al.  Interactions between cyclic AMP and inositol phosphate transduction systems in astrocytes in primary culture , 1990, Neuropharmacology.

[40]  J. Bockaert,et al.  Activation of 5-HT1A receptors expressed in NIH-3T3 cells induces focus formation and potentiates EGF effect on DNA synthesis. , 1992, Molecular biology of the cell.

[41]  A. Daszuta,et al.  Depletion in serotonin decreases neurogenesis in the dentate gyrus and the subventricular zone of adult rats , 1999, Neuroscience.

[42]  E. Azmitia,et al.  Stimulation of astroglial serotonin receptors produces culture media which regulates growth of serotonergic neurons , 1989, Brain Research.

[43]  M. Davies,et al.  Reduction of experimental vein graft intimal hyperplasia by ketanserin. , 1993, The Journal of surgical research.

[44]  B. Ahlemeyer,et al.  Stimulation of 5-HT1A receptor inhibits apoptosis induced by serum deprivation in cultured neurons from chick embryo. , 1997, Brain research.

[45]  M. B. Wilkie,et al.  Roles for Serotonin in Neurogenesis1 , 1983 .

[46]  E. Azmitia,et al.  5‐HT1A receptor localization on the axon hillock of cervical spinal motoneurons in primates , 1995, The Journal of comparative neurology.

[47]  M. Boranić,et al.  Serotonin and serotoninergic agents affect proliferation of normal and transformed lymphoid cells. , 1995, Immunopharmacology and immunotoxicology.

[48]  Amir C. Akhavan,et al.  Possible role of S-100 in glia—Neuronal signalling involved in activity-dependent plasticity in the developing mammalian cortex , 1993, Journal of Chemical Neuroanatomy.

[49]  J H Haring,et al.  Dentate granule cell function after neonatal treatment with parachloroamphetamine or 5,7-dihydroxytryptamine. , 1999, Brain research. Developmental brain research.

[50]  J. Staley,et al.  Developmental regulation of early serotonergic neuronal differentiation: the role of brain-derived neurotrophic factor and membrane depolarization. , 1995, Developmental biology.

[51]  Y. Claustre,et al.  Pharmacological characterization of serotonin-stimulated phosphoinositide turnover in brain regions of the immature rat. , 1988, The Journal of pharmacology and experimental therapeutics.

[52]  G. Fillion,et al.  Expression of serotonin receptors in human fetal astrocytes and glioma cell lines: a possible role in glioma cell proliferation and migration. , 1996, Brain research. Molecular brain research.

[53]  J. Alexander,et al.  Serotonin induced actin polymerization and association with cytoskeletal elements in cultured bovine aortic endothelium. , 1987, Biochemical and biophysical research communications.

[54]  T. Teyler,et al.  Anti-S-100 Serum blocks long-term potentiation in the hippocampal slice , 1986, Brain Research.

[55]  M. Martres,et al.  Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells. Relationship with the mitogenic action of serotonin. , 1999, Circulation research.

[56]  E. Azmitia,et al.  Stimulation of astroglial 5-HT1A receptors releases the serotonergic growth factor, protein S-100, and alters astroglial morphology , 1990, Brain Research.

[57]  D. Marshak,et al.  Purification and characterization of a neurite extension factor from bovine brain. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[58]  Joseph C. Shope,et al.  Intracellular delivery of phosphoinositides and inositol phosphates using polyamine carriers. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[59]  J. Lauder,et al.  Glial heterogeneity and developing neurotransmitter systems. , 1994, Perspectives on developmental neurobiology.

[60]  D. Nelson,et al.  Receptor subtype and density determine the coupling repertoire of the 5-HT2 receptor subfamily. , 1996, Life sciences.

[61]  E. Azmitia,et al.  Agonist‐ and antagonist‐induced plasticity of rat 5‐HT1A receptor in hippocampal cell culture , 1999, Synapse.

[62]  M. Blue,et al.  Regional Differences in the Ontogeny of the Serotonergic Projection to the Cerebral Cortex , 1996, Experimental Neurology.

[63]  J. Barnard,et al.  Morphologic changes in skeletal muscle induced by serotonin treatment: a light- and electron-microscope study. , 1967, Experimental and molecular pathology.

[64]  E. Azmitia,et al.  Serotonergic sprouting into transplanted C-6 gliomas is blocked by S-100 beta antisense gene. , 1995, Brain research. Molecular brain research.

[65]  M. Cynader,et al.  Autoradiographic localization of serotonin receptor subtypes in cat visual cortex: transient regional, laminar, and columnar distributions during postnatal development , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[66]  M. Riad,et al.  Neurotrophic effects of ipsapirone and other 5-HT1A receptor agonists on septal cholinergic neurons in culture. , 1994, Brain research. Developmental brain research.

[67]  R. Pakala,et al.  Mitogenic effect of serotonin on vascular endothelial cells. , 1994, Circulation.

[68]  M. Gillette,et al.  Serotonin regulates the phase of the rat suprachiasmatic circadian pacemaker in vitro only during the subjective day. , 1992, The Journal of physiology.

[69]  J. Lauder,et al.  Serotonin as a differentiation signal in early neurogenesis. , 1978, Developmental neuroscience.

[70]  S. Haldar,et al.  Microtubule-damaging drugs triggered bcl2 phosphorylation-requirement of phosphorylation on both serine-70 and serine-87 residues of bcl2 protein. , 1998, International journal of oncology.

[71]  J. Lagnado,et al.  Effects of indole alkaloids and related compounds on the properties of brain microtubular protein. , 1975, Biochemical Society transactions.

[72]  M. Meaney,et al.  Environmental Regulation of the Development of Glucocorticoid Receptor Systems in the Rat Forebrain. The Role of Serotonin , 1994, Annals of the New York Academy of Sciences.

[73]  J. Launay,et al.  5-HT2B receptor-mediated serotonin morphogenetic functions in mouse cranial neural crest and myocardiac cells. , 1997, Development.

[74]  M. Condorelli,et al.  Activated platelets and leucocytes cooperatively stimulate smooth muscle cell proliferation and proto-oncogene expression via release of soluble growth factors. , 1999, Cardiovascular research.

[75]  S. Snyder,et al.  Type 3 inositol 1,4,5‐trisphosphate receptor modulates cell death , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[76]  E. Azmitia,et al.  Activation of glycogen phosphorylase by serotonin and 3,4-methylenedioxymethamphetamine in astroglial-rich primary cultures: involvement of the 5-HT2A receptor , 1995, Brain Research.

[77]  E. Azmitia,et al.  5-HT1A agonist and dexamethasone reversal of para-chloroamphetamine induced loss of MAP-2 and synaptophysin immunoreactivity in adult rat brain , 1995, Brain Research.

[78]  J. Krieglstein,et al.  Neuroprotective effect of 5-HT1A receptor agonist, Bay X 3702, demonstrated in vitro and in vivo. , 1998, European journal of pharmacology.

[79]  Y. Takano,et al.  Apoptosis induced by microtubule disrupting drugs in cultured human lymphoma cells. Inhibitory effects of phorbol ester and zinc sulphate. , 1993, Pathology, research and practice.

[80]  R. Leven,et al.  Platelet Shape Change and Cytoskeletal Assembly: Effects of pH and Monovalent Cation lonophores , 1983, Thrombosis and Haemostasis.

[81]  P. Rakić,et al.  Neurotransmitter receptors in the proliferative zones of the developing primate occipital lobe , 1995, The Journal of comparative neurology.

[82]  K. Yamane,et al.  A Functional Interaction between the Human Papillomavirus 16 Transcription/Replication Factor E2 and the DNA Damage Response Protein TopBP1* , 2002, The Journal of Biological Chemistry.

[83]  E. Azmitia,et al.  Prenatal cocaine decreases the trophic factor S-100β and induced microcephaly: Reversal by postnatal 5-HT1A receptor agonist , 1994, Neuroscience Letters.

[84]  E. Azmitia,et al.  Colchicine-induced cytoskeletal collapse and apoptosis in N-18 neuroblastoma cultures is rapidly reversed by applied S-100β , 2001, Brain Research.

[85]  B. Ahlemeyer,et al.  The 5-HT1A receptor agonist Bay x 3702 inhibits apoptosis induced by serum deprivation in cultured neurons. , 1999, European journal of pharmacology.

[86]  J. HernándezRodríguez [Serotonin as a neurotrophic factor in the fetal brain: binding, capture and release in centers of axonal growth]. , 1994 .

[87]  D. Peters Both prenatal and postnatal factors contribute to the effects of maternal stress on offspring behavior and central 5-hydroxytryptamine receptors in the rat , 1988, Pharmacology Biochemistry and Behavior.

[88]  H. Tamir,et al.  Regulation by serotonin of tooth-germ morphogenesis and gene expression in mouse mandibular explant cultures. , 1998, Archives of oral biology.

[89]  T. Fahrig,et al.  The 5-HT1A receptor agonist BAY x 3702 prevents staurosporine-induced apoptosis. , 1998, European journal of pharmacology.

[90]  R. McKay,et al.  5-Hydroxytryptamine type 2A receptors regulate cyclic AMP accumulation in a neuronal cell line by protein kinase C-dependent and calcium/calmodulin-dependent mechanisms. , 1994, Molecular pharmacology.

[91]  R. Pakala,et al.  Effect of serotonin, thromboxane A2, and specific receptor antagonists on vascular smooth muscle cell proliferation. , 1997, Circulation.

[92]  G. Wilkin,et al.  Cultured astrocytes express messenger RNA for multiple serotonin receptor subtypes, without functional coupling of 5-HT1 receptor subtypes to adenylyl cyclase. , 1998, Brain research. Molecular brain research.

[93]  J. Haring,et al.  Hippocampal serotonin levels influence the expression of S100β detected by immunocytochemistry , 1993, Brain Research.

[94]  S. Binet,et al.  Spatial organization of microtubules in various types of cells in the embryonic tectal plate of mouse using immunofluorescence after PEG embedding , 1988, Biology of the cell.

[95]  E. Azmitia,et al.  Homologous regulation of 5-HT1A receptor mRNA in adult rat hippocampal dentate gyrus , 1999, Neuroscience Letters.

[96]  E. Azmitia Serotonin Neurons, Neuroplasticity, and Homeostasis of Neural Tissue , 1999, Neuropsychopharmacology.

[97]  Paul J. Harrison,et al.  Detection and quantitation of 5-HT1A and 5-HT2A receptor mRNAs in human hippocampus using a reverse transcriptase-polymerase chain reaction (RT-PCR) technique and their correlation with binding site densities and age , 1994, Neuroscience Letters.

[98]  E. Azmitia,et al.  [3H]5‐Hydroxytryptamine Binding to Brain Astroglial Cells: Differences Between Intact and Homogenized Preparations and Mature and Immature Cultures , 1986, Journal of neurochemistry.

[99]  P. Gluckman,et al.  Expanded ontogeny of neurotransmitters and their metabolites in the brains of fetal and newborn lambs. , 1990, Journal of developmental physiology.

[100]  S. Hamada,et al.  Serotonin 2A receptor-like immunoreactivity is detected in astrocytes but not in oligodendrocytes of rat spinal cord , 2001, Brain Research.

[101]  M. Hamon,et al.  Neuronal localization of 5-HT1A receptor mRNA and protein in rat embryonic brain stem cultures. , 1994, Brain research. Developmental brain research.

[102]  G. Majno,et al.  Acute endothelial cell contraction in vitro: a comparison with vascular smooth muscle cells and fibroblasts. , 1992, Microvascular Research.

[103]  U. Leli,et al.  Stimulation of Phosphoinositide Hydrolysis by Serotonin in C6 Glioma Cells , 1987, Journal of neurochemistry.

[104]  M. Pende,et al.  Expression of GAP‐43 in the Granule Cells of Rat Hippocampus After Seizure‐induced Sprouting of Mossy Fibres: In Situ Hybridization and Immunocytochemical Studies , 1994, The European journal of neuroscience.

[105]  M. Davies,et al.  Modulatory actions of serotonin on ionic conductances of hippocampal dentate granule cells , 1989, Neuroscience.

[106]  M. Fache,et al.  Identification and role of serotonin 5-HT1A and 5-HT1B receptors in primary cultures of rat embryonic rostral raphe nucleus neurons. , 2008, Journal of neurochemistry.

[107]  E. Azmitia,et al.  S100β promotes the extension of microtubule associated protein2 (MAP2)-immunoreactive neurites retracted after colchicine treatment in rat spinal cord culture , 1997, Neuroscience Letters.

[108]  E. Azmitia,et al.  Prenatal cocaine delays astroglial maturation: immunodensitometry shows increased markers of immaturity (vimentin and GAP-43) and decreased proliferation and production of the growth factor S-100. , 1996, Brain research. Developmental brain research.

[109]  A. Daszuta,et al.  Serotonin may stimulate granule cell proliferation in the adult hippocampus, as observed in rats grafted with foetal raphe neurons , 2000, The European journal of neuroscience.

[110]  M. Kirschner,et al.  Dynamic instability of microtubule growth , 1984, Nature.

[111]  C. J. Schmidt,et al.  Antagonism of the neurotoxicity due to a single administration of methylenedioxymethamphetamine. , 1990, European journal of pharmacology.

[112]  P. Nicotera,et al.  Colchicine induces apoptosis in cerebellar granule cells. , 1995, Experimental cell research.

[113]  C. Tisher,et al.  Role of apoptosis in development of the ascending thin limb of the loop of Henle in rat kidney. , 1996, The American journal of physiology.

[114]  M. Kaliner,et al.  The mast cell. , 1981, Critical reviews in immunology.

[115]  E. Azmitia,et al.  Enhanced synaptophysin immunoreactivity in rat hippocampal culture by 5‐HT1A agonist, S100b, and corticosteroid receptor agonists , 1996, Synapse.

[116]  Elizabeth Gould,et al.  Serotonin and Hippocampal Neurogenesis , 1999, Neuropsychopharmacology.

[117]  D. Mann,et al.  Activated Astrocytes Display Increased 5-HT2a Receptor Expression in Pathological States , 1999, Experimental Neurology.

[118]  E. Azmitia,et al.  Cellular Localization of the 5-HT1A Receptor in Primate Brain Neurons and Glial Cells , 1996, Neuropsychopharmacology.

[119]  D. S. Cowen,et al.  Activation of a Mitogen-activated Protein Kinase (ERK2) by the 5-Hydroxytryptamine1A Receptor Is Sensitive Not Only to Inhibitors of Phosphatidylinositol 3-Kinase, but to an Inhibitor of Phosphatidylcholine Hydrolysis* , 1996, The Journal of Biological Chemistry.

[120]  M. Hamon,et al.  Quantification of 5-hydroxytryptamine1a receptors in the cerebellum of normal and X-irradiated rats during postnatal development , 1992, Neuroscience.

[121]  R. Marois,et al.  Development of serotoninlike immunoreactivity in the embryonic nervous system of the snail Lymnaea stagnalis , 1992, The Journal of comparative neurology.

[122]  E. Azmitia,et al.  Trophic interactions between brain-derived neurotrophic factor and S100β on cultured serotonergic neurons , 2000, Brain Research.

[123]  E. Azmitia,et al.  Localization of 5‐HT1A receptors to astroglial cells in adult rats: Implications for neuronal‐glial interactions and psychoactive drug mechanism of action , 1993, Synapse.

[124]  M. Mikuni,et al.  Regulation of synapse density by 5-HT2A receptor agonist and antagonist in the spinal cord of chicken embryo , 1995, Neuroscience Letters.